Eric Ende
Président chez MATINAS BIOPHARMA HOLDINGS, INC.
Fortune : 6 M $ au 30/04/2024
Profil
Eric J.
Ende is the founder of Wellfit Holdings LLC.
He currently holds the position of Chairman at Matinas BioPharma Holdings, Inc. and Director at Matinas BioPharma, Inc. He is also a Director at Mesa Therapeutics, Inc. and an Independent Director at Avadel Pharmaceuticals Plc.
In addition, he is the President of Ende Consulting Group, Inc. and Ende Biomedical Consulting Group, Inc. His former positions include being a Director at Amylin Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc., Genzyme Corp., and NeuBase Therapeutics, Inc. He also worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith, Inc. Dr. Ende obtained his undergraduate degree from Emory University in 1990.
He holds an MBA from New York University and The Leonard N Stern School of Business, both conferred in 1997.
He also earned a doctorate from the Icahn School of Medicine at Mount Sinai in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2024 | 167 900 ( 0,19% ) | 3 M $ | 30/04/2024 | |
| 18/05/2023 | 167 900 ( 0,19% ) | 3 M $ | 30/04/2024 | |
| 18/03/2024 | 144 092 ( 0,06% ) | 26 225 $ | 30/04/2024 |
Postes actifs de Eric Ende
| Sociétés | Poste | Début |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Président | 01/10/2022 |
| AVADEL PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 01/12/2018 |
| Ende Consulting Group, Inc. | President | 07/03/2011 |
| Mesa Therapeutics, Inc. | Directeur/Membre du Conseil | - |
Wellfit Holdings LLC
 Wellfit Holdings LLC Information Technology ServicesTechnology Services Wellfit Holdings LLC provides computer programming services. The private company is based in Palm Beach Gardens, FL. The company was founded by Eric J. Ende. Eric J. Ende has been the CEO since incorporation. | Directeur Général | - |
Ende Biomedical Consulting Group, Inc.
 Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | President | 01/01/2009 |
| Matinas BioPharma, Inc. | Directeur/Membre du Conseil | 01/05/2017 |
Anciens postes connus de Eric Ende
| Sociétés | Poste | Fin |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/05/2023 |
| PROGENICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/06/2020 |
| ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Eric Ende
| New York University | Masters Business Admin |
| Icahn School of Medicine at Mount Sinai | Doctorate Degree |
| Emory University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 10 |
|---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
 Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Finance |
| Ende Consulting Group, Inc. | |
| Mesa Therapeutics, Inc. | |
Wellfit Holdings LLC
Wellfit Holdings LLC Information Technology ServicesTechnology Services Wellfit Holdings LLC provides computer programming services. The private company is based in Palm Beach Gardens, FL. The company was founded by Eric J. Ende. Eric J. Ende has been the CEO since incorporation. | Technology Services |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | Commercial Services |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| Matinas BioPharma, Inc. | |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
